Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Potassium citrate 3g/10mL mixture BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumcitrat 3 g brev granulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumcitrat 12 g/10 ml koncentreret mikstur |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 20 mækv/15 ml opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 20 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumglukonat 20 mækv/15 ml eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 1 g/ml opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 1 g/5 ml opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
Potassium chloride 20meq/15m solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid tablet 10 mækv 750 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 750 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 20 mækv tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 20 mækv granulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 15 mækv granulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
Potassium chloride 1.875 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
Potassium bicarbonate 25meq |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 20 mækv/pakke |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 15 mækv/pakke |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 8 mækv tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 10 mækv tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
Potassium chloride 750 mg10 meq tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium chloride 1.5 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 1,5 g |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 20 mækv/pk. opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
Potassium chloride 1500mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
Potassium chloride 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium chloride 1.5 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 8 mækv |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium bicarbonate 2.5 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 10 mækv tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium citrate 540 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium citrate 1.08 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 20 mækv/10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
citronsyre + monohydrat + kaliumcitrat 550 mg + natriumcitrat 500 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
citronsyremonohydrat 334 mg + kaliumcitrat 550 mg + natriumcitrat 500 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
citronsyremonohydrat 334 mg + kaliumcitrat 550 mg + natriumcitrat 500 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
citronsyremonohydrat 334 mg + kaliumcitrat 550 mg + natriumcitratdihydrat 500 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
citronsyremonohydrat 334 mg + kaliumcitrat 1100 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
citronsyremonohydrat 334 mg + kaliumcitrat 1100 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
kaliumtilskud |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
Product containing potassium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement (substance) |
Inferred relationship |
Some |
|
Providing potassium based on suboptimal food or fluid intake, iatrogenic deficiency or medical diagnosis. |
Direct substance |
True |
Potassium supplement (substance) |
Inferred relationship |
Some |
1 |